As A Breakthrough Drug For The Expansive Osteoporosis Market, Bogutai® (Teriparatide Injection) Has

EQS Newswire / 22/01/2024 / 09:00 UTC+8As A Breakthrough Drug For The Expansive Osteoporosis Market,Bogutai® (Teriparatide Injection) Has Been Officially Approved By The ChinaNational Medical Products Administration (NMPA) Hong Kong, 22 January 2024 - Uni-Bio Science Group Limited ("Uni-Bio", the "Company", tog...

Related Keywords

Hong Kong ,China ,Beijing ,Switzerland ,Shenzhen ,Guangdong ,Germany ,German ,Swiss ,Kingsley Leung ,Financial Press ,National Medical Products Administration ,Bio Science Group ,China National Medical Products Administration ,Bio Science Group Limited Uni ,Teriparatide Injection ,Has Been Officially Approved By The ,Medical Products Administration ,Bio Science Group Limited ,Osteoporosis Diagnosis ,Treatment Guideline ,Main Board ,Hong Kong Stock Exchange ,Financial Press Release ,